Pulmonary fibrosis is caused by a number of insults including exposure to asbestos. An increasing amount of evidence suggests that asbestos-associated toxicity to cells of the respiratory tract involves generation of oxygen free radicals, reactive species that cause lipid peroxidation, and damage to macro-molecules. Oxygen free radicals also are implicated as causative agents in inflammation in the lung associated with other fibrogenic agents (i.e., bleomycin, TPA). During the past year, we have developed a rapid-onset inhalation model of asbestos-induced inflammation and fibrosis in Fischer 344 rats and are able to measure lung injury by asbestos using biochemical and morphologic techniques. These include determination of protein, cell content, lipid content and activity of enzymes in the lavage fluid of exposed animals, hydroxyproline content of whole lung, and a histologic grading system for inflammation and fibrosis. These markers of inflammation and disease will be used to evaluate preventive intervention with scavengers of active oxygen species when administered to asbestos-exposed animals. First we will assess whether SOD and catalase (scavengers of superoxide (O2-) and H202, respectively) are elevated in rat lung and serum after administration of scavengers coupled to polyethylene glycol (PEG) or incorporated into liposomes. These procedures will increase the half-life of enzymes and facilitate their fusion with cell membranes. Secondly, scavengers, alone and in combination, will be administered to rats to prevent asbestos-associated inflammation and fibrosis. Thirdly, isolated alveolar macrophages and rat lung fibroblasts will be used to probe mechanisms of generation of active oxygen species by asbestos.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
2P50HL014212-16
Application #
3943186
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Quinlan, T R; Marsh, J P; Janssen, Y M et al. (1994) Dose-responsive increases in pulmonary fibrosis after inhalation of asbestos. Am J Respir Crit Care Med 150:200-6
Roggli, V L; Coin, P G; MacIntyre, N R et al. (1994) Asbestos content of bronchoalveolar lavage fluid. A comparison of light and scanning electron microscopic analysis. Acta Cytol 38:502-10
Quinlan, T; Spivack, S; Mossman, B T (1994) Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 102 Suppl 2:79-87
Mossman, B T; Janssen, Y M; Marsh, J P et al. (1991) Development and characterization of a rapid-onset rodent inhalation model of asbestosis for disease prevention. Toxicol Pathol 19:412-8
Mossman, B T; Marsh, J P; Sesko, A et al. (1990) Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 141:1266-71
Scott, S M; Buenaflor, G G; Orth, D N (1989) Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and placenta in full-term and preterm infants. Biol Neonate 56:246-51
Ramage Jr, J E; Roggli, V L; Bell, D Y et al. (1988) Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 137:1229-32
Fisher, G L; Mossman, B T; McFarland, A R et al. (1987) A possible mechanism of chrysotile asbestos toxicity. Drug Chem Toxicol 10:109-31
Mossman, B T; Gilbert, R; Doherty, J et al. (1986) Cellular and molecular mechanisms of asbestosis. Chest 89:160S-161S
Bell, D Y; Johnson, S M; Piantadosi, C A (1986) Elevated serum immunoglobulin G levels and bronchoalveolar lymphocytosis as predictors of clinical course in pulmonary sarcoidosis. Ann N Y Acad Sci 465:672-7

Showing the most recent 10 out of 11 publications